Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acumen Pharmaceuticals, Inc. (ABOS) Statistics
Valuation metrics
Market Cap 122.22M
Enterprise value 115.31M
Trailing P/E (ttm) -1.21
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 2.5
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 529.92K
Average volume (90 days) 461.77K
Price summary
52-Week low 1.5
52-Week high 3.6
Beta -
50-Day moving average 2.31
200-Day moving average 2.46
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.91%
Return on equity -1.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.53
Total debt (mrq) -
Total Debt/Equity (mrq) 0.55
Current ratio (mrq) 2.47%
Book value per share (mrq) 0.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
